Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Marta Mateo-Morales"'
Autor:
María del Carmen Vicente-Ayuso, María García-Roa, Ataúlfo González-Fernández, Ana María Alvarez-Carmona, Celina Benavente-Cuesta, Marta Mateo-Morales, Cristina Pérez-López, Ascensión Peña-Cortijo, Marta Polo Zarzuela, Laura Gutiérrez, Rafael Martínez-Martínez
Publikováno v:
Hematology Reports, Vol 9, Iss 3 (2017)
Acute promyelocytic leukemia (APL) has become a highly curable malignant disease after the introduction of all transretinoic acid (ATRA) to chemotherapy treatment. However, the risk to develop therapy-related myeloid neoplasms (t-MN) has become a mat
Externí odkaz:
https://doaj.org/article/6397ea9f4b5241ac809afc9c68f014f0
Autor:
Luciana del Campo Guerola, Ana Andrea García Sacristán, Antonio Portolés, Maricruz Jasso, Teresa Guerra-Galán, Eduardo de la Fuente-Munoz, María Palacios-Ortega, Miguel Fernández-Arquero, Cristina Cuesta-Mínguez, Aránzazu Rodríguez-Sanz, Ascensión Peña-Cortijo, Marta Polo, Marta Mateo Morales, Eduardo Anguita-Mandly, Teresa Benítez Jiménez, Celina Benavente Cuesta, Silvia Sánchez-Ramón
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
This is the first report of the health economic benefits derived from preventing infections through Immunoglobulin Replacement Therapy (IgRT) in patients with secondary immunodeficiency due to hematological malignancies. We conducted a retrospective
Externí odkaz:
https://doaj.org/article/0f71c95202484eca8f9dda9b12012b6b
Autor:
Juliana Ochoa-Grullón, Kissy Guevara-Hoyer, Cristina Pérez López, Rebeca Pérez de Diego, Ascensión Peña Cortijo, Marta Polo, Marta Mateo Morales, Eduardo Anguita Mandley, Carlos Jiménez García, Estefanía Bolaños, Belén Íñigo, Fiorella Medina, Antonia Rodríguez de la Peña, Carmen Izquierdo Delgado, Eduardo de la Fuente Muñoz, Elsa Mayol, Miguel Fernández-Arquero, Ataúlfo González-Fernández, Celina Benavente Cuesta, Silvia Sánchez-Ramón
Publikováno v:
Biomedicines, Vol 10, Iss 8, p 2020 (2022)
B cell chronic lymphoproliferative diseases (B-CLPD) are associated with secondary antibody deficiency and other innate and adaptive immune defects, whose impact on infectious risk has not been systematically addressed. We performed an immunological
Externí odkaz:
https://doaj.org/article/2c58009c0a8949bdb97d780d45554d89
Autor:
Ascensión Peña Cortijo, Silvia Sánchez-Ramón, Antonia Rodríguez de la Peña, Laura Conejero Hall, Juliana Ochoa-Grullón, Gustavo Cordero Torres, Edgard Rodríguez de Frías, Carmen M. Diez-Rivero, Miguel Fernández-Arquero, Cristina Pérez López, A. Fernández, Kissy Guevara-Hoyer, Celina Benavente Cuesta, Marta Mateo Morales
Publikováno v:
Frontiers in Immunology, Vol 11 (2021)
Frontiers in Immunology
Frontiers in Immunology
Infectious complications are a major cause of morbidity and mortality in B-cell hematological malignancies (HM). Prophylaxis for recurrent infections in HM patients with antibody deficiency consists of first-line antibiotics and when unsuccessful, ga
Autor:
Marta Mateo-Morales, Rafael Martínez-Martínez, Celina Benavente-Cuesta, Ana María Alvarez-Carmona, Laura Gutierrez, María del Carmen Vicente-Ayuso, Marta Polo Zarzuela, Ascensión Peña-Cortijo, Cristina Pérez-López, Ataúlfo González-Fernández, María García-Roa
Publikováno v:
Hematology Reports
Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid
Hematology Reports, Vol 9, Iss 3 (2017)
Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid
Hematology Reports, Vol 9, Iss 3 (2017)
Acute promyelocytic leukemia (APL) has become a highly curable malignant disease after the introduction of all transretinoic acid (ATRA) to chemotherapy treatment. However, the risk to develop therapy-related myeloid neoplasms (t-MN) has become a mat
Autor:
Lidia Fernández-Paredes, Ascensión Peña Cortijo, Marta Mateo Morales, Edgard Rodríguez de Frías, Rebeca Pérez de Diego, G. Cordero Torres, Silvia Sánchez-Ramón, Miguel Fernández-Arquero, Antonia Rodríguez de la Peña, Ana Alvarez Carmona, Cristina Pérez López, Celina Benavente Cuesta, Juliana Ochoa-Grullón, Kissy Guevara-Hoyer
Publikováno v:
Blood. 134:3600-3600
An increasing healthcare challenge in the management of hematological malignancy (HM) is secondary immunodeficiency (SID), either caused by the underlying malignancy or by treatments, including B-cell-targeting therapies. From January 2019, the EMA (
Autor:
Juliana Ochoa-Grullón, Celina Benavente Cuesta, Ataúlfo González Fernández, Gustavo Cordero Torres, Cristina Pérez López, Ascensión Peña Cortijo, Laura Conejero Hall, Marta Mateo Morales, Antonia Rodríguez de la Peña, Carmen M. Díez-Rivero, Edgard Rodríguez de Frías, Kissy Guevara-Hoyer, Miguel Fernández-Arquero, Silvia Sánchez-Ramón
Publikováno v:
Frontiers in Immunology, Vol 11 (2021)
Infectious complications are a major cause of morbidity and mortality in B-cell hematological malignancies (HM). Prophylaxis for recurrent infections in HM patients with antibody deficiency consists of first-line antibiotics and when unsuccessful, ga
Externí odkaz:
https://doaj.org/article/53578e113715410f8fad7a3f5a83abb6